Biohazard, DNA and Research - Clinical Research Informer

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Biohazard

DNA

Research

?5 Things You Need to Know from Our Recent Gene Therapy Webinar

Worldwide Clinical Trials

JUNE 15, 2022

We’ve also seen a decrease in available research nurses, as they have had to be reassigned to COVID patients. These therapies can have mechanisms that could expose people to biological or biohazardous agents, so therapies must be closely monitored and contained during transport, storage, and administration.

Gene Therapy

Gene Therapy Gene Clinical Trials Clinical Trials

IBC vs. IRB: What’s the Difference?

Advarra

JUNE 12, 2023

Gene therapy research is exciting and full of promise, but because of the risks involved, it’s also highly regulated, requiring an institutional biosafety committee (IBC) to provide additional oversight and risk assessment. IRBs are tasked with protecting research subject’s rights and welfare. What Does an IBC Review?

Genetic Engineering

Genetic Engineering Gene Therapy Genetics Engineer

?5 Things You Need to Know from Our Recent Gene Therapy Webinar

IBC vs. IRB: What’s the Difference?

Stay Connected